3-aryl-2-isoxazolines as antiinflammatory agents
US5686434A · kind A · utility
12Cited by
8References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 15, 1996 |
| Grant date | Nov 11, 1997 |
| Priority date | — |
| Expiry date | May 15, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/653
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to 3-aryl-2-isoxazoline compounds which are selective inhibitors of phosphodiesterase type IV (PDE.sub.IV). The 3-aryl-2-isoxazolines are useful in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease, psoriasis, allergic rhinitis, dermatitis, shock, atopic dermatitis, rheumatoid arthritis and osteoarthritis. This invention also relates to pharmaceutical compositions useful therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.